BamSEC and AlphaSense Join Forces
Learn More

Recursion Pharmaceuticals Inc.

NASDAQ: RXRX    
Share price (12/20/24): $6.03    
Market cap (12/20/24): $1.728 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 27 pages Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc
12/34/56
EX-3
from SC 13D/A ~5 pages This Joint Filing Agreement (This “Agreement”) Is Made and Entered Into as of This 4th Day of November, 2021, by and Among Mubadala Investment Company Pjsc, Mamoura Diversified Global Holdings Pjsc, MDC Capital Partners (Ventures) GP, LP, MDC Capital Partners (Ventures), LP, Mic Capital Partners (Public) (US) Im, LLC, Mic Capital Management Uk Llp and Mic Capital Partners (Public) Parallel Cayman, LP
12/34/56
EX-3.2
from 8-K 31 pages Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc
12/34/56
EX-3.1
from 8-K 13 pages Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc. a Delaware Corporation
12/34/56
EX-3.2
from S-1/A 13 pages Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc. a Delaware Corporation
12/34/56
EX-3.1
from S-1/A 19 pages Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc
12/34/56
EX-3.4
from S-1 31 pages Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc
12/34/56
EX-3.3
from S-1 20 pages Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc. Adopted April 23, 2020
12/34/56
EX-3.1
from S-1 17 pages Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc
12/34/56
EX-3.3
from DRS/A 20 pages Amended and Restated Bylaws of Recursion Pharmaceuticals, Inc. Adopted April 23, 2020
12/34/56
EX-3.1
from DRS/A 17 pages Amended and Restated Certificate of Incorporation of Recursion Pharmaceuticals, Inc
12/34/56